We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSBIP:NASDAQMidland States Bancorp, Inc. - Depositary Shares Each Representing a 1/40th Interest in a Share of 7.750% Fixed-Rate Reset Non-Cumulative Perpetual Preferred St Analysis

Data as of 2026-04-18 - not real-time

$25.18

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Midland States Bancorp (MSBIP) is trading at $25.18, just above its 20‑day ($24.93) and 50‑day ($25.17) SMAs and comfortably above the 200‑day SMA ($24.47), indicating short‑term price strength. The MACD histogram is positive (0.06) and the signal line is bearish, yielding a bullish MACD signal, while the RSI sits at 54, suggesting no immediate overbought pressure. However, volume has been decreasing (average 2,400 shares vs today’s 316), and the technical trend is classified as neutral, hinting at waning momentum.
Fundamentally, the bank reports $265 M in revenue with modest 2.8% growth, but it posts a negative profit margin (‑46.9%) and a ROE of ‑19%, reflecting earnings weakness. Despite a high dividend yield of 7.69%, the payout ratio is effectively zero and earnings per share are nil, raising serious questions about dividend sustainability. The upcoming Q1 2026 earnings release on April 23 is the only near‑term catalyst in the news flow.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD but decreasing volume
  • High dividend yield with unsustainable payout
  • Price near immediate resistance at $25.43

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Neutral technical trend and modest revenue growth
  • Continued earnings weakness and negative ROE
  • Potential pressure on dividend if earnings do not improve

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Persistent negative profitability metrics
  • Low beta but moderate volatility (12.7% 30‑day)
  • Liquidity concerns reflected by low trading volume

Key Metrics & Analysis

Financial Health

Revenue Growth278.70%
Profit Margin-46.88%
ROE-19.47%
ROA-1.77%
P/B Ratio1.2
Op. Cash Flow$125.7M
Industry P/E17.7

Technical Analysis

TrendNeutral
RSI54.0
Support$24.35
Resistance$25.43
MA 20$24.93
MA 50$25.17
MA 200$24.47
MACDBullish
VolumeDecreasing
Fear & Greed Index90.21

Valuation

GradeOvervalued
TypeValue
Dividend Yield7.69%

Risk Assessment

Beta0.10
Volatility12.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.